Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status
Top Cited Papers
- 1 July 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 62 (28) , 6535-6538
Abstract
Three phenotypes for urolithin production after ellagitannin and ellagic acid intake are consistently observed in different human intervention trials. Subjects can be stratified into three urolithin-producing groups. “Phenotype A” produced only urolithin A conjugates, which included between 25 and 80% of the volunteers in the different trials. “Phenotype B” produced isourolithin A and/or urolithin B in addition to urolithin A, this being the second relevant group (10–50%). “Phenotype 0” (5–25%) was that in which these urolithins were not detected. The three phenotypes were observed independently of the volunteers’ health status and demographic characteristics (age, gender, body mass index (BMI)) and of the amount or type of ellagitannin food source ingested (walnuts and other nuts, strawberries, raspberries, and other berries or pomegranates). Interestingly, a higher percentage of phenotype B was observed in those volunteers with chronic illness (metabolic syndrome or colorectal cancer) associated with gut microbial imbalance (dysbiosis). These urolithin phenotypes could show differences in the human gut microbiota and should be considered in intervention trials dealing with health benefits of ellagitannins or ellagic acid. Whether this phenotypic variation could be a biomarker related to differential health benefits or illness predisposition deserves further research.Keywords
Funding Information
- Consejería Economía, Innovación, Ciencia y Empleo, Junta de Andalucia (CSD2007-00063)
- Ministerio de Economía y Competitividad (AGL2011-22447)
- European Commission Directorate-General for Research and Innovation (BACCHUS FP7- 312090)
- Fundación Séneca Región de Murcia (GERM 06, 04486)
This publication has 15 references indexed in Scilit:
- Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patientsMolecular Nutrition & Food Research, 2014
- Time Course Production of Urolithins from Ellagic Acid by Human Gut MicrobiotaJournal of Agricultural and Food Chemistry, 2013
- Effects of ellagitannin‐rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndromeMolecular Nutrition & Food Research, 2013
- Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So FarEvidence-Based Complementary and Alternative Medicine, 2013
- Strawberry Processing Does Not Affect the Production and Urinary Excretion of Urolithins, Ellagic Acid Metabolites, in HumansJournal of Agricultural and Food Chemistry, 2011
- Ellagitannins, ellagic acid and vascular healthMolecular Aspects of Medicine, 2010
- Bioavailability of Anthocyanins and Ellagitannins Following Consumption of Raspberries by Healthy Humans and Subjects with an IleostomyJournal of Agricultural and Food Chemistry, 2010
- Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juiceMolecular Nutrition & Food Research, 2010
- Pomegranate Juice Ellagitannin Metabolites Are Present in Human Plasma and Some Persist in Urine for Up to 48 HoursThe Journal of Nutrition, 2006
- Metabolism of Antioxidant and Chemopreventive Ellagitannins from Strawberries, Raspberries, Walnuts, and Oak-Aged Wine in Humans: Identification of Biomarkers and Individual VariabilityJournal of Agricultural and Food Chemistry, 2004